Showing results (81-90 of 187) with videos related to
Sort By:
Pageof 19
International Journal of Hematology|February 18, 2014
Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation statusChika Kawajiri, Hiroaki Tanaka, Shinichiro Hashimoto, et al.European Journal of Haematology|December 18, 2007
CD44 and hyaluronan engagement promotes dexamethasone resistance in human myeloma cellsChikako Ohwada, Chiaki Nakaseko, Masayuki Koizumi, et al.Cancer Chemotherapy and Pharmacology|September 24, 2013
FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II studyMitsugu Kochi, Yuji Akiyama, Tatsuya Aoki, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|January 8, 2014
Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphomaKengo Fujimura, Hiroyuki Ebinuma, Isamu Fukamachi, et al.Cancer Science|January 6, 2011
Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft modelsTakahito Nakahara, Aya Kita, Kentaro Yamanaka, et al.Japanese Journal of Clinical Oncology|October 13, 2010
A randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancerKeiichi Fujiwara, Eriko Aotani, Tetsutaro Hamano, et al.Anti-Cancer Drugs|March 11, 2011
YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft modelTakahito Nakahara, Kentaro Yamanaka, Shinji Hatakeyama, et al.Lung Cancer (Amsterdam, Netherlands)|July 30, 2013
The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterationsKoji Tsuta, Mitsumasa Kawago, Eisuke Inoue, et al.Nature Reviews. Nephrology|March 20, 2014
Drug discovery in renal disease--towards a more efficient frameworkToshio Miyata, Tsuyoshi Ando, Hisami Hiragi, et al.Journal of the American Heart Association|April 7, 2017
Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating CardiomyopathyShigeru Miyagawa, Keitaro Domae, Yasushi Yoshikawa, et al.Pageof 19